SKYRIZI® Risankizumab-rzaa 60 mg / mL Injection Single-Dose Vial 10 mL

USAMP#77965707SKU: 00074501501SKYRIZI®
rxLicense

License Required

wishlistAltwishlistAlt
SKYRIZI® Risankizumab-rzaa 60 mg / mL Injection Single-Dose Vial 10 mL

Product Spotlight

  • SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
  • SKYRIZI is indicated for the treatment of active psoriatic arthritis in adults
  • SKYRIZI is indicated for the treatment of moderately to severely active Crohn's disease in adults
  • 600 mg/10 mL (60 mg/mL) single-dose vial